Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics

Add Alzheimer's disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new study says.

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported Thursday in the journal Alzheimer's & Dementia.

Advertisement